These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 311154

  • 1. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM, Hymas PG, Perkins HA.
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC, Deykin D.
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [Abstract] [Full Text] [Related]

  • 3. [Diagnosis of von Willebrand's disease].
    Baklaja R, Stojimirović E, Kezić J, Cuperlović K, Jovanović B, Cvetković V, Rasović N, Stajić M.
    Bilt Hematol Transfuz; 1977 Mar; 5(3-4):41-61. PubMed ID: 307953
    [Abstract] [Full Text] [Related]

  • 4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 5. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A, Miller JL, Neuberg RW, Gawryl MS, Hoyer LW.
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [Abstract] [Full Text] [Related]

  • 6. The spectrum of von Willebrand's disease revisited.
    Bowie EJ, Fass DN, Olson JD, Owen CA.
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [Abstract] [Full Text] [Related]

  • 7. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T, Dini E.
    Acta Haematol; 1975 Jan; 53(1):44-8. PubMed ID: 807074
    [Abstract] [Full Text] [Related]

  • 8. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ, Rogers J, Brand H.
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [Abstract] [Full Text] [Related]

  • 9. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P, Tamagnini GL, Dormandy KM.
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [Abstract] [Full Text] [Related]

  • 10. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ, Sussman II, Hoyer LW.
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [Abstract] [Full Text] [Related]

  • 11. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
    Mimaya J, Nagao T, Iizuka A, Yamashita H.
    Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
    [No Abstract] [Full Text] [Related]

  • 12. Determination of factor VIII-related antigen using commercial antisera.
    Chediak J, Maxey B, Telfer M.
    Am J Clin Pathol; 1977 May; 67(5):462-9. PubMed ID: 404869
    [Abstract] [Full Text] [Related]

  • 13. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y, Simeon J, Caen JP.
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [Abstract] [Full Text] [Related]

  • 14. [Diagnosis of von Willebrand's disease].
    Böttcher D, Hasler K, Winckelmann G, Sutor AH, Mair D.
    Med Klin; 1978 Jun 02; 73(22):833-8. PubMed ID: 307108
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD, Brockway WJ, Fass DN, Magnuson MA, Bowie EJ.
    Am J Clin Pathol; 1975 Feb 02; 63(2):210-8. PubMed ID: 1078748
    [Abstract] [Full Text] [Related]

  • 16. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR, Coller BS, Sultan Y.
    J Clin Invest; 1975 Oct 02; 56(4):814-27. PubMed ID: 1080491
    [Abstract] [Full Text] [Related]

  • 17. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D, Potter EV.
    J Lab Clin Med; 1976 Jun 02; 87(6):976-86. PubMed ID: 778313
    [Abstract] [Full Text] [Related]

  • 18. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K, Kubonishi I, Taguchi H, Miyoshi I.
    Acta Haematol; 1984 Jun 02; 71(3):158-64. PubMed ID: 6424380
    [Abstract] [Full Text] [Related]

  • 19. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR, Williams SB, Shafer BC, Corash L.
    Blood; 1982 Aug 02; 60(2):328-32. PubMed ID: 6807372
    [Abstract] [Full Text] [Related]

  • 20. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
    Cooper HA, Wagner RH.
    J Clin Invest; 1974 Nov 02; 54(5):1093-9. PubMed ID: 4213756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.